Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Ballesteros

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Psychopharmacology|March 2, 2005
Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear modelsJavier Ballesteros
Addiction (Abingdon, England)|October 16, 2008
[Commentary] quality improvement interventions for screening and treatment of at-risk drinkers need to be sustained and positively reinforced over time to maximize resultsJavier Ballesteros
Journal of Affective Disorders|March 17, 2004
Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trialsJavier Ballesteros, Luis F Callado
Atencion Primaria|March 8, 2011
[Is there room for improvement in the Spanish version of the scaled General Health Questionnaire (GHQ-28)?]Ander Retolaza Balsategui, Javier Ballesteros Rodriguez
Patient Preference and Adherence|February 3, 2012
The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophreniaJorge Mauriño, Luis Cordero, Javier Ballesteros
Medicina Clinica|March 2, 2015
[Painful generalized erythematous patches: A very rare cutaneous adverse effect of pemetrexed]María Castellanos-González, Javier Ballesteros Bargues
Atencion Primaria|June 8, 2006
[GHQ-60: review of its factorial structure in primary care patients]Ander Retolaza Balsategui, Javier Ballesteros Rodríguez
Journal of Clinical Psychopharmacology|April 7, 2007
An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorderJavier Ballesteros, Luis F Callado, Miguel Gutiérrez
Cancer Chemotherapy and Pharmacology|August 9, 2011
MTHFR 677TT genotype and toxicity of methotrexate: controversial resultsElixabet Lopez-Lopez, Javier Ballesteros, Africa Garcia-Orad
Elife|August 29, 2020
Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonistJesus Javier Ballesteros, Jessica Blair Briscoe, Yumiko Ishizawa
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Psychopharmacology|March 2, 2005
Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear modelsJavier Ballesteros
Addiction (Abingdon, England)|October 16, 2008
[Commentary] quality improvement interventions for screening and treatment of at-risk drinkers need to be sustained and positively reinforced over time to maximize resultsJavier Ballesteros
Journal of Affective Disorders|March 17, 2004
Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trialsJavier Ballesteros, Luis F Callado
Atencion Primaria|March 8, 2011
[Is there room for improvement in the Spanish version of the scaled General Health Questionnaire (GHQ-28)?]Ander Retolaza Balsategui, Javier Ballesteros Rodriguez
Patient Preference and Adherence|February 3, 2012
The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophreniaJorge Mauriño, Luis Cordero, Javier Ballesteros
Medicina Clinica|March 2, 2015
[Painful generalized erythematous patches: A very rare cutaneous adverse effect of pemetrexed]María Castellanos-González, Javier Ballesteros Bargues
Atencion Primaria|June 8, 2006
[GHQ-60: review of its factorial structure in primary care patients]Ander Retolaza Balsategui, Javier Ballesteros Rodríguez
Journal of Clinical Psychopharmacology|April 7, 2007
An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorderJavier Ballesteros, Luis F Callado, Miguel Gutiérrez
Cancer Chemotherapy and Pharmacology|August 9, 2011
MTHFR 677TT genotype and toxicity of methotrexate: controversial resultsElixabet Lopez-Lopez, Javier Ballesteros, Africa Garcia-Orad
Elife|August 29, 2020
Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonistJesus Javier Ballesteros, Jessica Blair Briscoe, Yumiko Ishizawa
Pageof 9